Keeping Pace® with Analytical Services

Subscribe to our blog here:

Should You Test for Legionella?

According to the Centers for Disease Control (CDC), Legionnaires’ disease is on the rise in the United States. In 2000, roughly 1000 cases were reported. That number ballooned to 10,000 cases in 2018, the last year for which data is available. The CDC issued a 2021 report on waterborne diseases, but this report only looks at cases of Legionellosis associated with an outbreak. Most cases of waterborne diseases, including Legionnaires’ disease, are sporadic, i.e., not epidemiologically linked to other cases by time, location of exposure to water, and type of illness.

Read More

USP 797 FAQs: Media Kits

Lately, the Pace® microbiology team has been fielding a lot of questions on how to interpret and implement different aspects of the revised USP <797> standard. Here are some of the most frequently asked questions regarding the use of sampling media kits.

Read More

Draft Method 1633 is not the Only Option for Analyzing PFAS in Non-Potable Water and Solids

December 2023

Many of our recent discussions around PFAS testing options involve Draft Method 1633. The most recent version, Draft 4, was published in June of 2023 and is considered “final” for wastewater, surface water, and groundwater. The EPA forecasts that the method will be finalized this December, 2023.

Read More

10 Tips for Proper Shipping of USP 797 Samples

The 2023 revisions to USP <797> increase compliance requirements for compounding pharmacies. Following proper handling and shipping procedures for lab media can help ensure all that extra effort doesn’t go to waste. Here are ten tips for ensuring your gloved fingertip and surface samples arrive safely.

Read More

Webinar Recap: What Do the Proposed PFAS MCLs Mean for You?

Whenever The United States Environmental Protection Agency (EPA) comes out with a new PFAS regulatory proposal, we inevitably get a lot of questions. The National Primary Drinking Water Regulations (NPDWR) proposed for PFAS on March 14th were no exception. While the EPA held a couple of informational webinars that were highly informative, the Pace® PFAS Team wanted to offer some clarity as well.

Read More

USP 797 BUDs: How the 2023 Changes Impact Environmental Monitoring Requirements

In November 2023, significant revisions to the United States Pharmacopeia (USP) General Chapter <797> will go into effect, bringing critical updates to the environmental monitoring standards governing the compounding of sterile preparations. In this post, we delve into the changes to USP 797 BUD standards and how they impact environmental testing requirements.

Read More